Moxifloxacin HCL 400 MG tablet UD 50S
Ended Awarded
- Contract number
- SPE2DR26F2PDQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,840
Award facts
- Contract value 100% obligated
- $24,840.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $24,840 delivery order to Amerisourcebergen Drug Corp on July 14, 2026, for moxifloxacin HCl 400 mg tablets under firm fixed-price terms. Ultimate completion date is July 15, 2026. Place of performance is Conshohocken, PA. The order carries no set-aside.
Quick answers
Who was awarded contract SPE2DR26F2PDQ?
SPE2DR26F2PDQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 14, 2026.
How much is contract SPE2DR26F2PDQ worth?
The government has obligated $24,840 on SPE2DR26F2PDQ.
Is contract SPE2DR26F2PDQ an order under another contract?
Yes. SPE2DR26F2PDQ is a delivery order under SPE2DR25D7064, an indefinite delivery contract.
Was contract SPE2DR26F2PDQ competed?
The extent of competition for SPE2DR26F2PDQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award